Bellus Health Inc

NASDAQ:BLU  
3.64
+0.19 (+5.51%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Bellus Health Inc Stock, NASDAQ:BLU

275 Armand-Frappier boulevard, Laval, Qu?©bec H7V 4A7
Phone: +1.450.680.4500
Number of Employees:

Description

BELLUS Health, Inc. is a biopharmaceutical development company which engages in the research and development of novel therapeutics for the treatment of chronic cough and other hypersensitisation disorders. Its product, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.